Skip to content

Mechanisms and Optimization of the Antidepressant Effects of High-Dose iTBS Guided by Resting-State fcMRI

Mechanisms and Optimization of the Antidepressant Effects of High-Dose iTBS Guided by Resting-State fcMRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123788
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression disorder

Interventions

Intervention group:Intermittent Theta-Burst Stimulation (iTBS)

Sponsors

Beijing Huilongguan Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for major depressive disorder or bipolar depressive episode according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 2.Aged >=18 years, with no restriction on sex; 3.A score of >=17 on the 17-item Hamilton Depression Rating Scale (HAMD-17); 4.Right-handed; normal vision or normal vision after correction; 5.On stable medication, with no changes throughout the intervention period (either medication-free or maintaining the same type and dosage of antidepressants); 6.Voluntarily participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Currently or previously diagnosed with other major psychiatric disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), excluding major depressive disorder or bipolar depressive episode (e.g., other psychotic disorders, substance-related and addictive disorders, substance/medication-induced psychotic disorders, neurodevelopmental disorders, or neurocognitive disorders); 2.Presence of serious physical illnesses at present that, in the investigator’s judgment, make the individual unsuitable for participation in this study; 3.Currently pregnant, within <=6 months postpartum, or breastfeeding; 4.Presence of major neurological disorders, or implantation of devices such as cardiac pacemakers or deep brain stimulation electrodes, rendering the individual unsuitable for receiving brain stimulation; 5.Individuals with a high current risk of suicide or those unable to cooperate with treatment and data collection; 6.Receipt of physical therapies such as ECT/MECT, VNS, or DBS within the past month.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale (HAMD) Score;Hamilton Anxiety Rating Scale (HAMA) Score;Self-Rating Anxiety Scale (SAS) Score;

Secondary

MeasureTime frame
Beck Depression Inventory (BDI) Score;

Countries

China

Contacts

Public ContactZhiren Wang

Beijing Huilongguan Hospital Affiliated to Capital Medical University

zhiren75@163.com+86 10 8302 4505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026